Individualized osilodrostat treatment for patients with ACTH-dependent Cushing’s syndrome: real-world evidence - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Personalized Osilodrostat Therapy for Individuals with ACTH-Dependent Cushing’s Syndrome: Insights from Real-World Data

  • By

  • Aleksandra Gilis-Januszewska

  • Aleksandra Gamrat-Żmuda

  • Mari Minasyan

  • Martyna Więcławek

  • Alicja Hubalewska-Dydejczyk

  • July 10, 2026

Share

Original Source(s)

Individualized osilodrostat treatment for patients with ACTH-dependent Cushing’s syndrome: real-world evidence

  • by Aleksandra Gilis-Januszewska, Aleksandra Gamrat-Żmuda, Mari Minasyan, Martyna Więcławek, Alicja Hubalewska-Dydejczyk

  • July 10, 2026

Related Content

Development and validation of a predictive model for diabetic kidney disease risk in patients with T2DM: a hospital data platform study

Association between metabolic risk factors and hepatocellular carcinoma: a systematic review and meta-analysis of cohort studies

Dietary Inflammatory Potential and Cardiometabolic Risk Factors in School-Aged Adolescents